Weight-loss drugs used in nearly one in 10 homes in Great Britain, study finds

rss · Guardian 2026-11-19T05:00:19Z en
About 2.6m adults are taking the drugs, fuelled by the regulator’s approval of the pill versions and a rise in male users At least one person is taking weight-loss drugs in 8.5% of households in Great Britain, according to research, meaning there are more homes with GLP-1 users than those containing vegetarians and pescatarians combined. About 2.6 million adults were using weight-loss medication in August, a rise of about 700,000 people since February, according to a survey by Worldpanel by Numerator. Continue reading...
At least one person is taking weight-loss drugs in 8.5% of households in Great Britain, according to research, meaning there are more homes with GLP-1 users than those containing vegetarians and pescatarians combined. About 2.6 million adults were using weight-loss medication in August, a rise of about 700,000 people since February, according to a survey by Worldpanel by Numerator. In February 6.3% of households had someone using GLP-1 drugs, rising to 8.5% in August. Weight-loss pills such as Wegovy were approved in the UK in June. Patients previously had to use the injectable version. Pills now account for more than one in 10 (11.2%) of GLP-1 users, while men are also driving the increase. Men make up just under a third (32%) of people taking weight-loss medication, up from 23% in February. Male users have nearly doubled to 830,000, up from 440,000 nine months ago. A once-a-day Wegovy weight-loss pill went on sale in high street pharmacies in Britain in July. Photograph: David Parry/PAThe increased use of medications such as Mounjaro and Wegovy is causing people to buy less food at the supermarket and change their buying habits, according to a survey of more than 9,600 households. In the year after starting to take the drugs, households with a GLP‑1 user collectively spent £1bn less on groceries than expected compared with similar households. In June, Worldpanel calculated the total saved by households with a GLP-1 user was £780m. This represents 415m fewer items bought, or £389 a year displaced from the shopping baskets of households with a GLP-1 user, according to the research by Worldpanel, which has been tracking the effects of the drugs on buying behaviour since March 2024. Nishita Pattni, a senior consultant for Worldpanel by Numerator, said: “In just six months, between February and August 2026, user numbers rose almost as much as they did in the whole of the previous year.“For many people, a daily pill is far easier than an injection, and with the surge in male users, we only expect the appeal of these drugs to grow.”GLP-1 users are now found in a similar percentage of households in Great Britain as those that buy popular branded products such as Kellogg’s Rice Krispies (8.6%) and Corona beer (8.4%). People taking weight-loss medication were not simply buying fewer groceries, the research found. Spend and volume were falling at a similar rate, creating winners and losers.skip past newsletter promotionafter newsletter promotionProducts associated with indulgence, as well as impulse purchases, have taken the biggest hit. Alcohol spend has fallen by 15% more among GLP-1 users than in households where no one uses GLP-1, while the spend on crisps has fallen by a similar percentage, as users tend to snack less. Conversely, portion-controlled products are growing in popularity. There has been a 30% rise in the number of frozen ready-meals sold, and an increase in the volume and spend on hot chocolate and malt drinks as people who take weight-loss drugs continue to enjoy small treats. Chantel Kennaugh, the head of public sector and nutrition for Worldpanel by Numerator, said estimates suggest that GLP-1 usage is likely to surpass 10% of households in Great Britain in 2027. “This is not a flash-in-the-pan trend, but a seismic change that requires retailers and manufacturers to rethink their strategies.”

Knowledge Graph

Entities
Highlight